Last reviewed · How we verify
Chlorhexidine 4.0%
At a glance
| Generic name | Chlorhexidine 4.0% |
|---|---|
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- ESP vs. EXORA Blocks for Analgesia in Laparoscopic Cholecystectomy (NA)
- The Effect of Chlorhexidine + Hyaluronic Acid on Postoperative Wound Healing After Lower Third Molar Removal (NA)
- A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI (NA)
- M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy (NA)
- Effects of Chlorhexidine Toothpaste on Wound Healing After Impacted Tooth Extraction (NA)
- Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality (PHASE3)
- Skin Prep to Reduce Postoperative Shoulder Infection (NA)
- Long-term Outcomes of Tunnel Technique
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chlorhexidine 4.0% CI brief — competitive landscape report
- Chlorhexidine 4.0% updates RSS · CI watch RSS
- Johns Hopkins Bloomberg School of Public Health portfolio CI